It is official: India is siding with poor cancer patients over profits for multinational drug giants.
The Supreme Court of India has rejected a plea by Swiss pharma giant Novartis that ends the seven-year legal battle to restrict Indian companies ...
26 WAYS TO PROFIT FROM ‘OBAMACARE’ $WLP $HCA $CYH $UHS $WCG $HUM $CNC $MRK $LLY $PFE $MDT $STJ
Obama has been re-elected; “Obamacare” is the law of the land. It doesn't matter if you agree or disagree with Obamacare, you might as well generate big profits from it.
Obamacare has been profitable for us. ...
TAKE PROFITS AND EXIT LLY
This post was published on ZYX Short Sell Change Alert
Consider taking profits and exiting LLY trade right here around $43.60. We will provide more details over the weekend.
TAKE PARTIAL PROFITS ON LLY
This post was published on ZYX Short Sell Change Alert
Consider taking profits on the last tranche from around $46 right here $43.40- 43.65. THis will leave 20% still held.
CAUTION ON LLY
This post was published on ZYX Short Sell Change Alert
We are repeating that conservative investors should not enter this trade. Even though the trial has failed and there is not enough life left in the patent, ...
ADD TO LLY
This post was published on ZYX Short Sell Change Alert
Consider adding another 10% tranche in the zone of $45.90 to $46.60.
DETAILS ON LLY TRIAL
This post was published on ZYX Short Sell Change Alert
The stock is likely to be very volatile, conservative investors should not enter this trade. The results of the trial are being misinterpreted by some in the market. Here ...
MORE ON LLY
This post was published on ZYX Short Sell Change Alert
Stock moved right after the post. Most fills should be $43.87. Consider adding 10% around $43.80-44.50.
NEW IDEA ON LLY
This post was published on ZYX Short Sell Change Alert
LLY Alzheimer drug trial has failed. Consider starting a 10% tranche right here around $42.82.
More later.
CHECK OUR PERFORMANCE
